Altogether, this proof-of-concept study, highlighting the powerful potential of LDLR-targeting peptides as vehicles for nuclear imaging probes and/or drugs, offers hopeful perspectives both in medical imaging for pre-operative diagnosis and in cancer treatments through fluorescence guided-surgery and targeted-drug delivery. Here, LDLR is linked to cancer.